Most site activation delays aren’t caused by complexity. They are caused by how we manage the complexity.In a recent article, WEP’s SVP, Head of Global Project Management, Jen Banks, outlined five key strategies to reduce [...]
At last year’s Operationalize Expanded Access Programs Summit, I explored a question that was on many Sponsors’ minds: "What is the value of collecting real world data in EAPs, and how can it support commercial [...]
Bringing clinical trial sites from selection to activation is one of the most time-sensitive and operationally complex phases of study start-up. Delays at this stage ripple across timelines, budgets, and ultimately patient access. Yet, accelerating [...]
Accelerating Vaccine Development Through Community-Based Pharmacy Clinical Infrastructure The partnership between WEP Clinical and RxE2 establishes a differentiated model for vaccine trial execution: one that leverages the accessibility of community pharmacies alongside global clinical [...]
A WEP Clinical White Paper With Every Patient In Recognition of International Childhood Cancer Day - February 15 Executive Summary Scientific innovation in pediatric oncology has accelerated, yet clinical trial participation among children with cancer [...]
A WEP Clinical White PaperWith Every PatientIn Recognition of World Cancer Day – February 4 Executive Summary Each year on World Cancer Day, the global oncology community reflects on both progress made and the work [...]
The FDA’s expectations around equitable access and representative enrollment in clinical research have moved from encouraged to operationally expected. With the FDA’s Enhancing Participation in Clinical Trials - Eligibility Criteria, Enrollment Practices, and Trial Designs final guidance (published December 15, [...]
A WEP Clinical White Paper With Every Patient Executive Summary Clinical trials have evolved significantly over the past several decades, driven by scientific innovation, regulatory modernization, and the increasing complexity of investigational therapies. Yet, despite [...]
WEP CLINICAL EXPANDS CLINICAL TRIAL HOME NURSING; APPOINTS JULIET HULSE TO LEAD GLOBAL OPERATIONS WEP Clinical (WEP), a full-service contract research organization (CRO), today announced the expansion of its Clinical Trial Home Nursing division with the [...]
WEP CLINICAL ACQUIRES NETHERLANDS-BASED CRO SIRON CLINICAL, EXPANDING GLOBAL PHASE I–IV TRIAL DELIVERY CAPABILITIES Morrisville, NC, USA & London, UK — [January 05, 2026] — WEP Clinical (WEP), a full-service contract research organization (CRO), today [...]
